Skip to main content

iRhythm Holdings, Inc.

corporate_fare Company Profile

iRhythm Holdings, Inc.

IRTC·NASDAQ·Industrial Applications And Services·CIK 0001388658

iRhythm is a digital healthcare company focused on solutions for detecting, predicting, and preventing disease. The company's main business involves designing, developing, and selling device-based technology for ambulatory cardiac monitoring services. These services aim to help clinicians diagnose certain arrhythmias more quickly and efficiently than traditional methods. Each iRhythm product combines a wire-free, patch-based, 14-day wearable biosensor, which is cleared by the United States Food and Drug Administration ("FDA"), marked with Conformité Européenne ("CE"), and approved by the Japan Pharmaceuticals and Medical Devices Agency ("PMDA") as applicable. This biosensor continuously records electrocardiogram ("ECG") data and works with a proprietary cloud-based data analytic software, also FDA-cleared, CE-marked, and Japan PMDA-approved as applicable. Together, this biosensor and software form an "iRhythm ACM System" used by physicians to monitor patients and diagnose arrhythmias. Since receiving FDA clearance for its technology in 2009, iRhythm has provided ambulatory cardiac monitoring ("ACM") services, including long-term continuous monitoring ("LTCM") services and mobile cardiac telemetry ("MCT") monitoring services, from its Medicare-enrolled independent diagnostic testing facilities ("IDTFs") with qualified technicians. These services are typically ordered by physicians for patients suspected of having infrequent, difficult-to-detect, or asymptomatic arrhythmias. Since FDA clearance, iRhythm has provided over twelve million patient reports and collected almost three billion hours of curated heartbeat data. iRhythm Technologies was incorporated in Delaware in September 2006, and its successor registrant, iRhythm Holdings, was incorporated in Delaware in December 2025. As of December 31, 2025, the company employs approximately 2,400 regular full-time employees.

iRhythm Holdings, Inc. (NASDAQ:IRTC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 25 items for IRTC at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • iRhythm's Zio ECG Portfolio Shows Broad Benefits at ACC.26; Company Launches New Clinician Education Platform
  • iRhythm Holdings Appoints UnitedHealth Group Executive Jason Patten to Board
  • iRhythm Holdings Reports Strong 2025 Financials Amid Escalating Legal & Regulatory Scrutiny
  • iRhythm Holdings Reports First-Ever Quarterly GAAP Net Income and Positive Annual Free Cash Flow
  • iRhythm Technologies Reorganizes into Holding Company Structure, Reports Strong Preliminary Q4 2025 Results and Positive 2026 Outlook

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$747.14M
Net Income
-$44.55M
Diluted EPS
-$1.39
Op. Cash Flow
$80.86M
Free Cash Flow
$34.52M
Gross Profit
$527.25M
Operating Income
-$57.41M
Cash & Equivalents
$236.01M
Debt / Equity
0.00×
Net Margin
-6.0%
Shares Outstanding
32.3M sh
Source: 10-K · filed 2026-02-19 · accession 0001388658-26-000011
$93.7 -1.08% today
52-week range · as of 2026-11-05 $93.7 – $192.47
Market cap
$3.18B
Volume
875.3K (1.0× avg)
3-mo avg 880.3K
Live data · 2026-11-22 12:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IRTC - Filings & News (Page 2)

IRTC
Mar 30, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $118.10
Real-time Price: $93.70 info
Change: -$24.40 (-21%) info
Market Cap: $3.184B info
IRTC
Mar 12, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $114.67
Real-time Price: $93.70 info
Change: -$20.97 (-18%) info
Market Cap: $3.184B info
IRTC
Feb 19, 2026, 5:30 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $161.00
Real-time Price: $93.70 info
Change: -$67.30 (-42%) info
Market Cap: $3.184B info
IRTC
Feb 19, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $160.50
Real-time Price: $93.70 info
Change: -$66.80 (-42%) info
Market Cap: $3.184B info
IRTC
Jan 12, 2026, 9:17 AM EST
Filing Type: 8-K12B
Importance Score:
8
Price at Filing: $180.00
Real-time Price: $93.70 info
Change: -$86.30 (-48%) info
Market Cap: $3.184B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets